Please Wait
Applying Filters...
Menu
Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/06/23/3103263/0/en/Denovo-Biopharma-LLC-Enters-into-an-Exclusive-Out-License-Agreement-with-Chuang-Yi-Global-Asset-Management-Co-Ltd-for-Biomarker-Guided-DB104-liafensine-in-Patients-with-Treatment-R.html

GLOBENEWSWIRE
23 Jun 2025

https://www.globenewswire.com/news-release/2025/06/06/3095010/0/en/Denovo-Biopharma-Announces-Formation-of-Neuroscience-Scientific-Advisory-Board-to-Advance-Precision-Medicine-in-Depression.html

GLOBENEWSWIRE
06 Jun 2025

https://www.prnewswire.com/news-releases/fda-grants-fast-track-designation-for-biomarker-guided-db104-liafensine-in-patients-with-treatment-resistant-depression-trd-302270948.html

PR NEWSWIRE
09 Oct 2024

https://www.prnewswire.com/news-releases/denovo-biopharma-llc-to-present-positive-phase-2b-enlighten-trial-data-for-dgm4-biomarker-guided-db104-liafensine-treatment-for-treatment-resistant-depression-at-the-ascp-2024-annual-meeting-302152321.html

PR NEWSWIRE
28 May 2024